FDA warning letter · Drugs

Join Josie

Issued · Posted by FDA

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

The compounded semaglutide and tirzepatide products displayed on your website identify “Join Josie” on the pictured label, suggesting Join Josie is the compounder of those drugs when in fact it is not.

Passage 2

“The same active ingredient found in the FDA-approved brand Wegovy®.”

Passage 3

“The same active ingredient found in the FDA-approved brand Zepbound®.”

Citations in the original letter

As cited in this historical letter, not a statement of current regulatory requirements.

  • 21 CFR 201.1(h)(2)
  • 21 CFR 201.1(a)